US EditionImmunocore (NASDAQ:IMCR) Research Coverage Started at Deutsche Bank Aktiengesellschaft
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Immunocore (NASDAQ:IMCR) Research Coverage Started at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft initiated coverage on shares of Immunocore (NASDAQ:IMCR – Free Report) in a report issued on Tuesday, MarketBeat reports. The brokerage issued a buy rating and a $65.00 price objective on the stock. IMCR has been the subject of several other reports. Oppenheimer upped their price objective on shares of Immunocore from $85.00 […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
